PET/MRI in Infection and Inflammation

Area of Science:

• Medical Imaging
• Radiopharmaceuticals
• Hybrid Imaging Systems

Background:

• Hybrid positron emission tomography/magnetic resonance imaging (PET/MR) systems are increasingly available for clinical applications.
• PET/MR integrates MR's soft tissue contrast and specialized sequences with PET's quantitative physiological data.
• Current evidence for PET/MR clinical utility is strongest in neuroimaging, with growing potential in oncology and other fields.

Purpose of the Study:

• To review the potential applications of hybrid PET/MR imaging for infection and inflammation.
• To provide background on relevant radiopharmaceuticals used in PET/MR.
• To discuss technical considerations for implementing PET/MR in clinical practice.

Main Methods:

• Review of existing literature on hybrid PET/MR imaging.
• Discussion of radiopharmaceutical properties and selection criteria.
• Analysis of technical aspects and challenges in PET/MR implementation.

Main Results:

• PET/MR shows significant promise for neuroimaging, head and neck, abdominal, and pelvic tumors.
• Emerging applications in cardiovascular and musculoskeletal infection/inflammation imaging are promising but in early stages.
• The combination of MR and PET provides comprehensive diagnostic information.

Conclusions:

• Hybrid PET/MR imaging holds substantial potential for diagnosing infection and inflammation.
• Further research and clinical investigation are needed to realize the full clinical utility of PET/MR in these areas.
• PET/MR represents a significant advancement in multimodal diagnostic imaging.